What is Biotesting?
Biotesting operates as a critical infrastructure partner for home developers, property managers, and private homeowners. By providing essential environmental diagnostics—including asbestos, mold, and lead paint testing—the firm serves as a vital link in the real estate and construction supply chain. With over three decades of industry experience, the company has established a reputation for technical precision and regulatory expertise, ensuring that indoor air quality and industrial hygiene standards are met with rigorous scientific oversight. Their role is increasingly significant as urban development faces heightened scrutiny regarding environmental safety and health compliance.
How much funding has Biotesting raised?
Biotesting has raised a total of $363K across 1 funding round:
Debt
$363K
Debt (2024): $363K with participation from Northeast Bank
Key Investors in Biotesting
Northeast Bank
A financial institution providing commercial banking and debt financing solutions to support the growth and operational stability of established enterprises.
What's next for Biotesting?
The recent influx of capital is expected to catalyze the expansion of Biotesting's service portfolio and geographic reach. By leveraging this late-stage financing, the company is well-positioned to invest in advanced diagnostic technologies and potentially broaden its consulting footprint beyond the Los Angeles metropolitan area. As regulatory requirements for property safety become more stringent, Biotesting's ability to provide comprehensive, data-backed environmental assessments will likely drive sustained demand. The firm is now focused on optimizing its operational efficiency to meet the growing needs of large-scale developers and institutional property managers, ensuring long-term viability in a sector where safety and compliance are paramount.
See full Biotesting company page
